Advantage Investment Management’s Cellectis CLLS Stock Holding History

Advantage Investment Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2K	Hold	200	–	–	﹤0.01%	844
2019 Q2	$3K	Hold	200	–	–	﹤0.01%	827
2019 Q1	$4K	Hold	200	–	–	﹤0.01%	780
2018 Q4	$3K	Hold	200	–	–	﹤0.01%	837
2018 Q3	$6K	Hold	200	–	–	﹤0.01%	819
2018 Q2	$6K	Hold	200	–	–	﹤0.01%	730
2018 Q1	$6K	Hold	200	–	–	﹤0.01%	761
2017 Q4	$6K	Hold	200	–	–	﹤0.01%	781
2017 Q3	$6K	Hold	200	–	–	﹤0.01%	784
2017 Q2	$5K	Hold	200	–	–	﹤0.01%	828
2017 Q1	$5K	Hold	200	–	–	﹤0.01%	804
2016 Q4	$3K	Hold	200	–	–	﹤0.01%	801
2016 Q3	$5K	Hold	200	–	–	﹤0.01%	726
2016 Q2	$5K	Hold	200	–	–	﹤0.01%	694
2016 Q1	$6K	Hold	200	–	–	﹤0.01%	652
2015 Q4	$6K	Buy	+200	New	+$6.07K	﹤0.01%	656

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Advantage Investment Management's CLLS Position: Q3 2019 in Review

Advantage Investment Management held its Cellectis (CLLS) position steady in Q3 2019 at 200 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Advantage Investment Management first reported a position in CLLS in Q4 2015 and has held it in 16 quarters since. The position peaked at $6K in Q3 2018. 64 funds tracked by Wall St. Rank hold CLLS as of Q3 2019.

Advantage Investment Management held 200 shares of Cellectis worth $2K as of Q3 2019.
Advantage Investment Management left its Cellectis share count unchanged in Q3 2019.
Cellectis made up ﹤0.01% of Advantage Investment Management's portfolio in Q3 2019, its #844 holding.
Advantage Investment Management first reported a position in Cellectis in Q4 2015 and has held it in 16 quarters since.
Advantage Investment Management's Cellectis position peaked at $6K in Q3 2018.
64 funds tracked by Wall St. Rank held Cellectis as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.